We studied the molecular mechanisms involved in the postantibiotic effect of the fluoroquinolones levofloxacin and moxifloxacin in Streptococcus pneumoniae. Wild-type strain R6 had postantibiotic effects of 2.05 Ϯ 0.10 h (mean Ϯ standard deviation [SD]) and 3.23 Ϯ 0.45 h at 2.5ϫ and 10ϫ MIC of levofloxacin, respectively. Moxifloxacin exhibited lower effects of 0.87 Ϯ 0.1 and 2.41 Ϯ 0.29 h at 2.5ϫ and 10ϫ MIC, respectively. Fluoroquinolone-induced chromosome fragmentation was measured at equivalent postantibiotic effects for levofloxacin (2.5ϫ MIC) and moxifloxacin (10ϫ MIC). After 2 h of drug removal, reductions were approximately 7-fold for levofloxacin and 3-fold for moxifloxacin, without further decreases at later times. Variations in reactive oxygen species production were detected after 4 to 6 h of drug withdrawals, with decreases Ն400-fold for levofloxacin and Ն800-fold for moxifloxacin at 6 h. In accordance, after 4 to 6 h of drug withdrawal, the levofloxacin-induced upregulation of the fatCDEB operon, introducing iron in the bacteria, decreased up to 2-to 3-fold, and the moxifloxacin-induced upregulation of several genes involved in the production of pyruvate was reduced 3-to 7-fold. In accordance, lower postantibiotic effects (up to 1 h) were observed in strain R6 ΔspxB, lacking the main enzyme involved in oxygen peroxide production, than in R6. Although no change in the recovery of chromosome fragmentation was observed between R6 and R6 ΔspxB, 3.5 ϫ 10 3 -fold lower reactive oxygen species production was observed in R6 ΔspxB, without changes after drug removal. These results show that reactive oxygen species are the main factors directing the postantibiotic effect of levofloxacin and moxifloxacin in S. pneumoniae.